Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P2.05 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Radiotherapy
- Presentations: 58
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.05-001 - α7-nAchR Agonist GTS-21 Reduces Radiation-Induced Lung Injury by Inhibiting HMGB1/TLR-4/NF-κB Pathway
14:30 - 14:30 | Author(s): Z. Mei
- Abstract
Loading... -
+
P2.05-002 - CACNA2D1 Enhances Radio-Resistance in Cancer Stem-Like Cells in NSCLC
14:30 - 14:30 | Author(s): X. Sui
- Abstract
Loading... -
+
P2.05-003 - PIK3CA Mutation is Associated with Increased Local Failure in Lung Stereotactic Body Radiation Therapy (SBRT)
14:30 - 14:30 | Author(s): N.A. Lockney
- Abstract
Loading... -
+
P2.05-004 - ABT-737, a BH3 Mimetic, Enhances Therapeutic Effect of Ionizing Radiation in Murine Lung Cancer Model
14:30 - 14:30 | Author(s): J.M. Lee
- Abstract
Loading... -
+
P2.05-005 - Mechanism of Radiotherapy in Reduction/Delay of T790M-Mediated EGFR TKI Resistance
14:30 - 14:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P2.05-006 - Radiotherapy as Definitive Treatment in Patients Aged 70 Years and Older with Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): S. Sarihan
- Abstract
Loading... -
+
P2.05-007 - Outcomes after Stereotactic Body Radiothrapy/Proton Beam Therapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer
14:30 - 14:30 | Author(s): Y. Ohde
- Abstract
Loading... -
+
P2.05-008 - Can Stereotactic Body Radiation Therapy (SBRT) Be an Effective Treatment for Lung Metastases From "Radioresistant" Histologies?
14:30 - 14:30 | Author(s): D. Franceschini
- Abstract
Loading... -
+
P2.05-009 - The Outcome and Adverse Event of Chemoradiation ± Surgery for Stage III Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): S. Kudo
- Abstract
Loading... -
+
P2.05-010 - Stereotactic Radioterapy (SBRT) for Primary and Metastatic Lung Tumors in Elderly Patients
14:30 - 14:30 | Author(s): L. Larrea
- Abstract
Loading... -
+
P2.05-011 - The Current Status of Radiotherapy in the Definitive Treatment of Lung Cancer in a Developing Country: Turkey
14:30 - 14:30 | Author(s): D. Yalman
- Abstract
Loading... -
+
P2.05-012 - Definitive Radiotherapy and Survival in Lung Cancer: Results from a Brazillian Cohort Study
14:30 - 14:30 | Author(s): M.H. Leal
- Abstract
Loading... -
+
P2.05-013 - Stereotactic Brain Radiosurgery in Lung Cancer Patients in the Era of Personalized Therapy: A Review of Outcomes and Prognostic Scores Evaluation
14:30 - 14:30 | Author(s): F.S. Mok
- Abstract
Loading... -
+
P2.05-014 - Sites of Recurrent Disease in SCLC Patients Treated with Radiochemotherapy - Is Selective Nodal Irradiation Safe?
14:30 - 14:30 | Author(s): C. Gumina
- Abstract
Loading... -
+
P2.05-015 - Long-Term Outcomes of Prospective Phase П Clinical Trial for Stereotactic Ablation Radiotherapy in Recurrent NSCLC
14:30 - 14:30 | Author(s): J.Y. Chang
- Abstract
Loading... -
+
P2.05-016 - Higher Dose of Radiotherapy Better for Outcome of Patients with Locally Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): M. Vrankar
- Abstract
Loading... -
+
P2.05-017 - Tumor Regression Gradient Predicts Disease Free Survival
14:30 - 14:30 | Author(s): P. Berkovic
- Abstract
Loading... -
+
P2.05-018 - Re-Irradiation Using SBRT: A Good Option as a Salvage Treatment in Pulmonary Lesions
14:30 - 14:30 | Author(s): J. Mases-Rosines
- Abstract
Loading... -
+
P2.05-019 - Stereotactic Body Radiotherapy (SBRT) for Central Lung Tumors: The Experience of Florence University-Careggi Hospital Radiotherapy
14:30 - 14:30 | Author(s): V. Scotti
- Abstract
Loading... -
+
P2.05-020 - Survival Outcomes in Stage 1 NSCLC Following Stereotactic Ablative Radiotherapy or Conventional Radiotherapy
14:30 - 14:30 | Author(s): G.G. Hanna
- Abstract
Loading... -
+
P2.05-021 - Stereotactic Radiosurgery for Brain Metastasis in Non-Small Cell Lung Cancer: Predictor of Intracranial Progression
14:30 - 14:30 | Author(s): Y.S. Kim
- Abstract
Loading... -
+
P2.05-022 - Is Post-Chemotherapy Tumor Volume Sufficient RT Target Volume in Patients with LD-SCLC?
14:30 - 14:30 | Author(s): I.Y. Jo
- Abstract
Loading... -
+
P2.05-023 - Patterns of Failure after Adjuvant Radiation Therapy Based On "Tumor Bed with Margin" for Stage III Thymic Epithelial Tumor
14:30 - 14:30 | Author(s): K.H. Lee
- Abstract
Loading... -
+
P2.05-024 - Current Status of Stereotactic Body Radiation Therapy (SBRT) in Japan
14:30 - 14:30 | Author(s): Y. Nagata
- Abstract
Loading... -
+
P2.05-025 - 9-Year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer
14:30 - 14:30 | Author(s): D. Bernhardt
- Abstract
Loading... -
+
P2.05-026 - Postoperative Radiotherapy in Non-Small Cell Lung Cancer: 20 Years' Experience in a Single Centre
14:30 - 14:30 | Author(s): F. Sert
- Abstract
Loading... -
+
P2.05-027 - Effects of Thermo-Chemotherapy for Lung Cancer Induced by Nano-Paclitaxel Magnetic Fluid
14:30 - 14:30 | Author(s): R. Hu
- Abstract
Loading... -
+
P2.05-028 - Comparison of Adjuvant Chemotherapy with or without Radiotherapy in NSCLC Patients with Stage IIIA-Single Station N2
14:30 - 14:30 | Author(s): J. Ni
- Abstract
Loading... -
+
P2.05-029 - Microwave Thermal Therapy Enhances Radiosensitivity of Highly Invasive Human Non-Small Cell Lung Cancer H460 Cells via Inhibiting DNA Repair
14:30 - 14:30 | Author(s): Y. Zhao
- Abstract
Loading... -
+
P2.05-030 - WBRT Prior EGFR TKIs is Effective Treatment Option for NSCLC Patients with CNS Metastases Harboring EGFR Mutation
14:30 - 14:30 | Author(s): P. Krawczyk
- Abstract
Loading... -
+
P2.05-031 - The Clinical Impact of Different Chemotherapy Regimen Combined with Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Li
- Abstract
Loading... -
+
P2.05-032 - CT-Based Surrogates of Pulmonary Ventilation in Lung Cancer: A Voxel-Level Comparison with HP Gas MRI
14:30 - 14:30 | Author(s): B. Tahir
- Abstract
Loading... -
+
P2.05-033 - Predictors of Survival after Whole Brain Radiotherapy for Patients with Brain Metastasized Lung Cancer
14:30 - 14:30 | Author(s): G. Tsakonas
- Abstract
Loading... -
+
P2.05-034 - New 3D «All in 1» Device for Fiducial Tumor Marking: A Pilot Animal Study
14:30 - 14:30 | Author(s): B. Escarguel
- Abstract
Loading... -
+
P2.05-035 - Interim Analysis of the Phase II Trial Dose Risk Adapted FFF Using SBRT in Stage I NSCLC and Lung Metastases (NCT01823003)
14:30 - 14:30 | Author(s): A. Navarro-Martin
- Abstract
Loading... -
+
P2.05-036 - Single Fraction of SBRT for Pulmonary Lesions
14:30 - 14:30 | Author(s): N. Aymar
- Abstract
Loading... -
+
P2.05-037 - Higher Radiation Dose is Still Promising in Patients with Complete Response to 50 Gy of Early Thoracic Radiotherapy with Chemotherapy?
14:30 - 14:30 | Author(s): W. Jeon
- Abstract
Loading... -
+
P2.05-038 - Initial Clinical Experience of VMAT-SBRT with Flattening-Filter-Free Techniques in the University of Tokyo Hospital
14:30 - 14:30 | Author(s): S. Aoki
- Abstract
Loading... -
+
P2.05-039 - Assessment of Lung Tumour Motion Comparing 4DCT, 4DCBCT and Motion of Implanted Beacons during Imaging and Irradiation
14:30 - 14:30 | Author(s): E. Steiner
- Abstract
Loading... -
+
P2.05-040 - Interobserver Variability in the Definition of the Primary Lung Cancer and Lymph Nodes on Different 4DCT Reconstructions
14:30 - 14:30 | Author(s): S. Mercieca
- Abstract
Loading... -
+
P2.05-041 - Accelerated Radical Radiotherapy for Non Small Cell Lung Cancer: Single Centre Experience of Two Fractionations
14:30 - 14:30 | Author(s): S. Robinson
- Abstract
Loading... -
+
P2.05-042 - Development of Thoracic Magnetic Resonance Imaging (MRI) for Radiotherapy Planning
14:30 - 14:30 | Author(s): H. Bainbridge
- Abstract
Loading... -
+
P2.05-043 - Lung Tumour Motion Kilovoltage Intrafraction Monitoring (KIM): First Clinical Results
14:30 - 14:30 | Author(s): C. Huang
- Abstract
Loading... -
+
P2.05-044 - Influence of Technological Advances and Institutional Experience on Outcome of Stereotactic Body Radiotherapy for Lung Metastases
14:30 - 14:30 | Author(s): J. Hoerner-Rieber
- Abstract
Loading... -
+
P2.05-045 - Accelerated Radical Radiotherapy for Non Small Cell Lung Cancer: Single Centre Experience of Two Schedules in the Treatment of Elderly Patients
14:30 - 14:30 | Author(s): S. Robinson
- Abstract
Loading... -
+
P2.05-046 - Is Delineating Clinical Target Volume a Must for Medium and Late Stages of Non-Small Cell Lung Cancer?
14:30 - 14:30 | Author(s): J. Li
- Abstract
Loading... -
+
P2.05-047 - Feasibility Study: Assessment of RT Dose Using Cardiac MRI Contouring Methodology on Retrospective Lung Planning CT Scans
14:30 - 14:30 | Author(s): N. Mohammed
- Abstract
Loading... -
+
P2.05-048 - Directional Characteristics of Motion Marker in CBCT for Target Localization for Lung Stereotactic Body Radiotherapy (SBRT)
14:30 - 14:30 | Author(s): K. Li
- Abstract
Loading... -
+
P2.05-049 - Radical Treated NSCLC Radiotherapy Patients: A Prospective Study of Toxicities and Outcomes
14:30 - 14:30 | Author(s): N. Hatton
- Abstract
Loading... -
+
P2.05-050 - Impact of Inflammation and Sarcopenia on Outcomes after Stereotactic Body Radiotherapy for T1N0M0 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): Y. Matsuo
- Abstract
Loading... -
+
P2.05-051 - Safety of Lung Stereotactic Body Radiotherapy (SBRT): A Single Institution Prospective Study Based on RTOG 0915 Protocol Constraints
14:30 - 14:30 | Author(s): V. Vanoni
- Abstract
Loading... -
+
P2.05-052 - A Systematic Review and Meta-Analysis of Pneumonitis in Radically Treated NSCLC Patients: SABR. vs. Non-SABR Treatment
14:30 - 14:30 | Author(s): F. Hegi-Johnson
- Abstract
Loading... -
+
P2.05-053 - Discussion and Analysis of Pneumonitis Related to Stereotactic Radiotherapy in Our Hospital
14:30 - 14:30 | Author(s): K. Imasaka
- Abstract
Loading... -
+
P2.05-054 - Radiation Pneumonitis; Early Diagnosis and Protein Expression Profile in NSCLC Patients
14:30 - 14:30 | Author(s): S. Aso
- Abstract
Loading... -
+
P2.05-055 - 90 Day Mortality and Survival Following Radical Radiotherapy for Non-Small Cell Lung Cancer Treated in the Dorset Cancer Centre, UK
14:30 - 14:30 | Author(s): S.K. Prince
- Abstract
Loading... -
+
P2.05-056 - Safety of Stereotactic Body Radiotherapy for Central, Ultracentral, and Paramediastinal Lung Tumors
14:30 - 14:30 | Author(s): M.E. Daly
- Abstract
Loading... -
+
P2.05-057 - Baseline Inflammatory and Immunological Profile Predict the Survival of NSCLC Patients Undergone Palliative Radiotherapy
14:30 - 14:30 | Author(s): P. Pastina
- Abstract
Loading... -
+
P2.05-058 - Blood Biomarkers of Inflammation, Tumour Burden and Proliferation Predict Radiotherapy Response and Toxicity in Lung Cancer
14:30 - 14:30 | Author(s): A. Salem
- Abstract
Loading...
-
+
P2.06 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Scientific Co-Operation/Research Groups (Clinical Trials in Progress should be submitted in this category)
- Presentations: 47
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.06-001 - A Study of MGCD516, a Receptor Tyrosine Kinase (RTK) Inhibitor, in Molecularly Selected Patients with NSCLC or Other Advanced Solid Tumors
14:30 - 14:30 | Author(s): T.L. Werner
- Abstract
Loading... -
+
P2.06-002 - Phase I Study of DS-6051b, a ROS1/NTRK Inhibitor, in Japanese Subjects with Advanced Solid Tumors Harboring Either a ROS1 or NTRK Fusion Gene
14:30 - 14:30 | Author(s): K. Nosaki
- Abstract
Loading... -
+
P2.06-003 - A Phase Ib Study of the Combination of Afatinib and Ruxolitinib in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) Progressed on EGFR-TKI
14:30 - 14:30 | Author(s): J.S. Park
- Abstract
Loading... -
+
P2.06-004 - A Phase 1b Study of Erlotinib and Momelotinib for EGFR TKI Naïve EGFR Mutated Metastatic Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): S.K. Padda
- Abstract
Loading... -
+
P2.06-005 - Phase 1 Study of Ramucirumab or Necitumumab in Combination with Osimertinib (AZD9291) in Advanced T790M-Positive EGFR-Mutant NSCLC
14:30 - 14:30 | Author(s): D. Planchard
- Abstract
Loading... -
+
P2.06-006 - Phase I/II Dose Escalation Study of L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients
14:30 - 14:30 | Author(s): R. Ramlau
- Abstract
Loading... -
+
P2.06-007 - A Phase 1/2 Trial of the Oral EGFR/HER2 Inhibitor AP32788 in Non–Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): R.C. Doebele
- Abstract
Loading... -
+
P2.06-008 - Phase 1/2 Study of Mocetinostat and Durvalumab (MEDI4736) in Patients with Advanced Solid Tumors and Non Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): M. Haigentz
- Abstract
Loading... -
+
P2.06-009 - Combined PKCι and mTOR Inhibition in Advanced or Recurrent Lung Cancer, Preliminary Report of an Ongoing Phase I/II Trial
14:30 - 14:30 | Author(s): H.J. Ross
- Abstract
Loading... -
+
P2.06-010 - AZD9291 as 1st-Line Therapy for EGFR Mutant NSCLC Patients with Concomitant Pretreatment EGFR T790M Mutation. The AZENT Study
14:30 - 14:30 | Author(s): N. Karachaliou
- Abstract
Loading... -
+
P2.06-011 - Phase 2 Study of MM-121 plus Chemotherapy vs. Chemotherapy Alone in Heregulin-Positive, Locally Advanced or Metastatic NSCLC
14:30 - 14:30 | Author(s): L.V. Sequist
- Abstract
Loading... -
+
P2.06-012 - Phase 2 Study of Abemaciclib + Pembrolizumab in KRAS Mutation, PD-L1+, Stage IV Non-Small Cell or Squamous Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Mazieres
- Abstract
Loading... -
+
P2.06-013 - Afatinib in Patients with Advanced HER2 Mutation-Positive (M+) NSCLC Previously Treated with Chemotherapy
14:30 - 14:30 | Author(s): C. Zhou
- Abstract
Loading... -
+
P2.06-014 - Phase 2 Study of Glesatinib or Sitravatinib with Nivolumab in Non-Small Cell Lung Cancer (NSCLC) after Checkpoint Inhibitor Therapy
14:30 - 14:30 | Author(s): J. Nemunaitis
- Abstract
Loading... -
+
P2.06-015 - The NICE Salvage Study: A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): T. Niwa
- Abstract
Loading... -
+
P2.06-016 - Phase 2 Study of Ramucirumab plus Weekly Docetaxel in Stage IV NSCLC Following Progression after Platinum-Based Chemotherapy
14:30 - 14:30 | Author(s): M. Sebastian
- Abstract
Loading... -
+
P2.06-017 - Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in Patients with Advanced or Metastatic NSCLC with Activating Genetic Alterations in MET
14:30 - 14:30 | Author(s): L. Bazhenova
- Abstract
Loading... -
+
P2.06-018 - Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: TORG1426
14:30 - 14:30 | Author(s): Y. Ichikawa
- Abstract
Loading... -
+
P2.06-019 - A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): D. Owen
- Abstract
Loading... -
+
P2.06-020 - A Open-Label Randomised Controlled Trial of First-Line Genexol-PM/ CrEL-Based Paclitaxel plus Cisplatin in Advanced NSCLC Patients
14:30 - 14:30 | Author(s): B. Han
- Abstract
Loading... -
+
P2.06-021 - Efficacy and Safety of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment in Subjects with EGFRMut+ NSCLC
14:30 - 14:30 | Author(s): R.J. Kelly
- Abstract
Loading... -
+
P2.06-022 - First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study
14:30 - 14:30 | Author(s): T. Mok
- Abstract
Loading... -
+
P2.06-023 - A Phase III Study Comparing Gefitinib and Inserted Cisplatin plus Pemetrexed with Gefitinib for EGFR-Mutated Advanced Non-Squamous NSCLC
14:30 - 14:30 | Author(s): S. Kanda
- Abstract
Loading... -
+
P2.06-024 - Tedopi vs Standard Treatment as 2nd or 3rd Line in HLA-A2 Positive Advanced NSCLC Patients in a Phase 3, Randomized Trial: ATALANTE-1
14:30 - 14:30 | Author(s): B. Besse
- Abstract
Loading... -
+
P2.06-025 - DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In
14:30 - 14:30 | Author(s): A. Nowak
- Abstract
Loading... -
+
P2.06-026 - A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress
14:30 - 14:30 | Author(s): W. Lam
- Abstract
Loading... -
+
P2.06-027 - Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Metastatic Pleural Mesothelioma
14:30 - 14:30 | Author(s): R. Hassan
- Abstract
Loading... -
+
P2.06-028 - A Phase 2 Study of Prexasertib in Patients with Extensive Stage Small Cell Lung Cancer
14:30 - 14:30 | Author(s): L.A. Byers
- Abstract
Loading... -
+
P2.06-029 - Pilot Window-Of-Opportunity Study of Pembrolizumab in Patients with Resectable Malignant Pleural Mesothelioma (MPM)
14:30 - 14:30 | Author(s): H. Lee Kindler
- Abstract
Loading... -
+
P2.06-030 - Optimum Duration of Vitamin B12/Folate Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy: The PEMVITASTART Randomized Trial
14:30 - 14:30 | Author(s): N. Singh
- Abstract
Loading... -
+
P2.06-031 - QUADRUPLE THREAT: A Pilot Phase 2 Study of RRx-001 in Advanced Lung Cancer Prior to Re-Administration of Platinum Doublets
14:30 - 14:30 | Author(s): C. Brzezniak
- Abstract
Loading... -
+
P2.06-032 - Oral Pioglitazone for the Chemoprevention of Lung Cancer in Current and Former Smokers
14:30 - 14:30 | Author(s): R.L. Keith
- Abstract
Loading... -
+
P2.06-033 - Long-Term Safety and Efficacy of Darbepoetin Alfa in Subjects with Advanced Stage NSCLC Receiving Multi-Cycle Chemotherapy
14:30 - 14:30 | Author(s): J.R. Gage
- Abstract
Loading... -
+
P2.06-034 - METIS: A Phase 3 Study of Radiosurgery with TTFields for 1-10 Brain Metastases from NSCLC
14:30 - 14:30 | Author(s): M.P. Mehta
- Abstract
Loading... -
+
P2.06-035 - Exploring Recruitment Factors in a Feasibility Trial of SABR versus Surgery
14:30 - 14:30 | Author(s): J.C. Bestall
- Abstract
Loading... -
+
P2.06-036 - LUNAR - A Phase 3 Trial of TTFields in Combination with PD-1 Inhibitors or Docetaxel for 2nd Line Treatment of Non-Small-Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): U. Weinberg
- Abstract
Loading... -
+
P2.06-037 - A Feasibility Study of Concurrent Chemoradiation Followed by Surgery for Pathologically-Proven Clinical IIIA-N2 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H. Yokomise
- Abstract
Loading... -
+
P2.06-038 - An RCT of the Detection of Autoantibodies to Tumour Antigens in Lung Cancer Using the EarlyCDT-Lung Test in Scotland (ECLS) in 12 208 Study Subjects
14:30 - 14:30 | Author(s): F. Sullivan
- Abstract
Loading... -
+
P2.06-039 - Searching for Standards: Multicenter Ring Trials to Evaluate Technologies for the Enrichment of Circulating Tumor Cells
14:30 - 14:30 | Author(s): S. Bender
- Abstract
Loading... -
+
P2.06-040 - WINNERS Study: Does a Formal Interactive Patient Education Program Positively Impact Patient Outcomes and Satisfaction after Thoracic Surgery
14:30 - 14:30 | Author(s): M. Culligan
- Abstract
Loading... -
+
P2.06-041 - TeleNursing: A Thoracic Surgery Nursing Initiative Aimed at Decreasing Hospital Readmissions and Increasing Patient Satisfaction
14:30 - 14:30 | Author(s): M. Culligan
- Abstract
Loading... -
+
P2.06-042 - Evaluate the Utility of the Computed Bioconductance Measurement in the Diagnosis of Lung Cancer
14:30 - 14:30 | Author(s): D. Yang
- Abstract
Loading... -
+
P2.06-043 - 3-Dimensional High Throughput Multi-Drug Screening Using Patient-Derived Tumor Cells (PDC) Established from Surgical Specimens of NSCLC
14:30 - 14:30 | Author(s): S. Shin
- Abstract
Loading... -
+
P2.06-044 - Frequency of Mutations and Related Factors in Lung Adenocarcinoma Cases in Turkey
14:30 - 14:30 | Author(s): S. Yilmaz
- Abstract
Loading... -
+
P2.06-045 - Initiative for Early Lung Cancer Research on Treatment (IELCART)
14:30 - 14:30 | Author(s): R. Flores
- Abstract
Loading... -
+
P2.06-046 - Shaping and Optimization of the Non-Small Cell Lung Cancer (NSCLC) Diagnostic Landscape in Australia and New Zealand (ANZ)
14:30 - 14:30 | Author(s): A. Khanna
- Abstract
Loading... -
+
P2.06-047 - LRRK2-In-1 Inhibit Proliferation of Doublecortin and CaM Kinase-Like-1 (DCLK1)-Positive Lung Cancer Cells
14:30 - 14:30 | Author(s): H. Tao
- Abstract
Loading...
-
+
P2.07 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Nurses
- Presentations: 10
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.07-001 - Non-Negotiated Companion Influence on Information Exchange at Lung Cancer Clinic Consultations
14:30 - 14:30 | Author(s): A. Smith
- Abstract
Loading... -
+
P2.07-002 - Evaluation of Providing Healthcare Information for Lung Mass Patients after Surgery
14:30 - 14:30 | Author(s): D. Khunyotying
- Abstract
Loading... -
+
P2.07-003 - What Do People Living with and Surviving Lung Cancer and Mesothelioma Want and Need from a Recovery Care Package?
14:30 - 14:30 | Author(s): J. Roberts
- Abstract
Loading... -
+
P2.07-004 - Social Support and Number of Symptoms One Month after Lung Cancer Surgery
14:30 - 14:30 | Author(s): T. Oksholm
- Abstract
Loading... -
+
P2.07-005 - Narratives from High Risk Respiratory Patients Who Had Bronchoscopy with Limited Sedation and Analgesia
14:30 - 14:30 | Author(s): C.F. Saxon
- Abstract
Loading... -
+
P2.07-006 - Combined Application of Two Biological Medicines with Healthcare and Health Education in Systemic Therapy Clinic
14:30 - 14:30 | Author(s): I. Tominc
- Abstract
Loading... -
+
P2.07-007 - Thoracic Oncology Research from Concept to Home-run (TORCH): Building Research Capacity in Lung Cancer Nursing
14:30 - 14:30 | Author(s): M.G. Coates
- Abstract
Loading... -
+
P2.07-008 - Victorian Comprehensive Cancer Centre Lung Cancer Clinical Audit: Collecting the UK National Lung Cancer Audit data from Hospitals in Australia
14:30 - 14:30 | Author(s): L. Mileshkin
- Abstract
Loading... -
+
P2.07-009 - Lung Function after Pulmonary Resection in Lung Cancer
14:30 - 14:30 | Author(s): P. Mikkelsen
- Abstract
Loading... -
+
P2.07-010 - Hospital Readmission Rates within 30 Days Following Thoracic Oncology Surgery
14:30 - 14:30 | Author(s): M. King
- Abstract
Loading...
-
+
P2.08 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Patient Support and Advocacy Groups
- Presentations: 15
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.08-001 - Giving a Voice to Patients and Caregivers through the Lung Cancer Canada ‘Faces of Lung Cancer’ Survey
14:30 - 14:30 | Author(s): M.K. Doherty
- Abstract
Loading... -
+
P2.08-002 - Online Patient Education in Advanced Lung Cancer: Effect on Patient/Caregiver Knowledge
14:30 - 14:30 | Author(s): T. Herrmann
- Abstract
Loading... -
+
P2.08-003 - Quality of Life and Patient Reported Outcome Measures for Lung Cancer Patients; Treatment Outcomes, and Patient Management
14:30 - 14:30 | Author(s): W. Boerckel
- Abstract
Loading... -
+
P2.08-004 - The Importance of Patient Recall within Cancer Survivorship Care for Improved Post-Treatment Surveillance in Lung Cancer Survivors
14:30 - 14:30 | Author(s): L. Backhus
- Abstract
Loading... -
+
P2.08-005 - Treating Cachexia-Anorexia in Lung Cancer Patients: Understanding the Patient Perspective on Novel Treatment Approaches
14:30 - 14:30 | Author(s): U. Basu Roy
- Abstract
Loading... -
+
P2.08-006 - Attempts to Improve the Patient Literacy in Japan
14:30 - 14:30 | Author(s): T. Yamaoka
- Abstract
Loading... -
+
P2.08-007 - Listen Advocate Voice - Web-Survey for the Japanese Model of Lung Cancer Advocacy by Society
14:30 - 14:30 | Author(s): T. Sawa
- Abstract
Loading... -
+
P2.08-008 - Regional Clinical Pathway for Lung Cancer in Kumamoto University Hospital
14:30 - 14:30 | Author(s): T. Mori
- Abstract
Loading... -
+
P2.08-009 - Need for Consistent Language around Biomarker Testing in the Diagnosis and Treatment of Lung Cancer
14:30 - 14:30 | Author(s): S. Mantel
- Abstract
Loading... -
+
P2.08-010 - The Reach and Adoption of a Multidisciplinary Thoracic Oncology Program within a U.S. Community Healthcare System
14:30 - 14:30 | Author(s): F.E. Rugless
- Abstract
Loading... -
+
P2.08-011 - Fashion Forward: Stigma Busting in Style in Egypt
14:30 - 14:30 | Author(s): M. Rigney
- Abstract
Loading... -
+
P2.08-012 - Evaluation of Lung Cancer Support Group Participation: Preliminary Results
14:30 - 14:30 | Author(s): M. Rigney
- Abstract
Loading... -
+
P2.08-013 - Integrated Complementary 'Energy' Therapy Improves Patient Experience of a Lung Cancer Diagnosis
14:30 - 14:30 | Author(s): G. Russell
- Abstract
Loading... -
+
P2.08-014 - Lung Cancer Awareness and Barriers to Primary Care in Ireland
14:30 - 14:30 | Author(s): A. McNamara
- Abstract
Loading... -
+
P2.08-015 - Promoting Lung Cancer Awareness in Ireland - Balancing Traditional and Digital Platforms
14:30 - 14:30 | Author(s): A. McNamara
- Abstract
Loading...
-
+
PA04 - Focus on Advocacy and Communication: Joint IASLC/ Global Lung Cancer Coalition Session (GLCC)
- Type: Patient & Advocacy Session
- Track: Patient Support and Advocacy Groups
- Presentations: 4
- Moderators:A. McNamara
- Coordinates: 12/06/2016, 14:30 - 15:45, Schubert 6
-
+
PA04.01 - A Realistic Goal? Achieving a Tobacco Free Ireland by 2025
14:30 - 14:45 | Author(s): D. Buggy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PA04.02 - The Global State of Lung Cancer Research – Communicating the Messages
14:45 - 15:05 | Author(s): S. Winstone
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PA04.03 - Helpline: Adapting to Changing Needs and Evolving Science
15:05 - 15:25 | Author(s): J.C. King
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PA04.04 - How it Feels Campaign: The Impact of a Large General Public Campaign
15:25 - 15:45 | Author(s): K. Bayne
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PC02 - By 2030 Chemotherapy will Remain Standard of Care for the Majority of Patients with NSCLC Stages I-IV
- Type: Pro Con
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 4
- Moderators:E. Felip
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall C7
-
+
PC02.01 - Introduction & Vote
14:30 - 14:45 | Author(s): G. Pall
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC02.02 - Pro Chemotherapy
14:45 - 15:05 | Author(s): N. Hanna
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC02.03 - Contra Chemotherapy
15:05 - 15:25 | Author(s): K. Kelly
- Abstract
Loading... -
+
PC02.04 - Discussion & Vote
15:25 - 15:45 | Author(s): E. Felip
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SC16 - Superior Sulcus Tumors
- Type: Science Session
- Track: Radiology/Staging/Screening
- Presentations: 4
- Moderators:D. Jones
- Coordinates: 12/06/2016, 14:30 - 15:45, Lehar 1-2
-
+
SC16.01 - Imaging Techniques for Staging and Restaging of Superior Sulcus Tumors
14:30 - 14:50 | Author(s): H. Prosch
- Abstract
No abstract available for this presentation
-
+
SC16.02 - Surgical Approaches in Superior Sulcus Tumors
14:50 - 15:10 | Author(s): D. Grunenwald
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC16.03 - Radiotherapy for Sulcus Superior Tumors
15:10 - 15:30 | Author(s): M. Werner-Wasik
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC16.04 - Individualized Extended Lung Cancer Surgery: The Chinese Experience
15:30 - 15:45 | Author(s): Q. Zhou
- Abstract
Loading...Information from this presentation has been removed upon request of the author.
-
+
ED10 - Locally Advanced NSCLC: State-of-the-Art Treatment
- Type: Education Session
- Track: Locally Advanced NSCLC
- Presentations: 5
- Moderators:W. Eberhardt
- Coordinates: 12/06/2016, 16:00 - 17:30, Hall C1
-
+
ED10.01 - Chemoradiotherapy of Stage III NSCLC
16:00 - 16:25 | Author(s): F. Mornex
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED10.02 - The Role of Surgery in Stage III NSCLC
16:25 - 16:45 | Author(s): W. Klepetko
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED10.03 - New Developments in Radiotherapy of Stage III NSCLC
16:45 - 17:05 | Author(s): J. Jassem
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED10.04 - New Developments for Systemic Therapies in Stage III NSCLC
17:05 - 17:25 | Author(s): E.E. Vokes
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED10.05 - Q&A
17:25 - 17:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
IA07 - Interactive Session Target Delineation: Group II (Ticketed Session)
- Type: Interactive Session
- Track: Radiotherapy
- Presentations: 1
- Moderators:K. Dieckmann
- Coordinates: 12/06/2016, 16:00 - 17:30, Schubert 3
-
+
IA07.01 - Interactive Session Target Delineation
16:00 - 17:30 | Author(s): C. Faivre-Finn
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
IA08 - Tobacco & Youth
- Type: Interactive Session
- Track: Epidemiology/Tobacco Control and Cessation/Prevention
- Presentations: 5
- Moderators:C. Radu
- Coordinates: 12/06/2016, 16:00 - 17:30, Hall C2
-
+
IA08.01 - Tobacco Use in Low-Income Countries
16:00 - 16:20 | Author(s): N. Yamaguchi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
IA08.02 - Tobacco Use in Austrian Young People
16:20 - 16:40 | Author(s): D. Jahn-Kuch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
IA08.03 - How Technology can Assist in Lung Cancer Prevention
16:40 - 17:00 | Author(s): A. Prokhorov
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
IA08.04 - Tobacco Control Policies and Youth Smoking
17:00 - 17:20 | Author(s): F. Mihaltan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Q&A
17:20 - 17:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev
